Clinical trial
INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders (ASD)
NCT01788072 is registered in ClinicalTrials.gov with Holland Bloorview Kids Rehabilitation Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders (ASD)
- Lead sponsor
- Holland Bloorview Kids Rehabilitation Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- October 31, 2017
- Enrollment
- 70 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.